Search

Your search keyword '"Holzer, Ursula"' showing total 219 results

Search Constraints

Start Over You searched for: Author "Holzer, Ursula" Remove constraint Author: "Holzer, Ursula"
219 results on '"Holzer, Ursula"'

Search Results

2. Clinical trio genome sequencing facilitates the interpretation of variants in cancer predisposition genes in paediatric tumour patients

3. Impact of newborn screening for SCID on the management of congenital athymia

4. Prospective Newborn Screening for SCID in Germany: A First Analysis by the Pediatric Immunology Working Group (API)

6. Long-Term Outcomes and Quality of Life of High-Risk Neuroblastoma Patients Treated with a Multimodal Treatment Including Anti-GD2 Immunotherapy: A Retrospective Cohort Study.

7. The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma

8. Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations

11. Impact of newborn screening for SCID on the management of congenital athymia

16. Impact of newborn screening for SCID on the management of congenital athymia

18. Anti-GD2 Antibody Dinutuximab Beta and Low-Dose Interleukin 2 After Haploidentical Stem-Cell Transplantation in Patients With Relapsed Neuroblastoma: A Multicenter, Phase I/II Trial

21. Rare and potentially fatal ‐ Cytogenetically cryptic TNIP1::PDGFRB and PCM1::FGFR1 fusion leading to myeloid/lymphoid neoplasms with eosinophilia in children

22. Haploidentical hematopoietic stem cell transplantation as individual treatment option in pediatric patients with very high-risk sarcomas

23. Human CARMIL2 deficiency underlies a broader immunological and clinical phenotype than CD28 deficiency

24. Prospective Newborn Screening for SCID in Germany: A first analysis by the Pediatric Immunology Working Group (API)

26. Genetic modifiers of fetal hemoglobin affect the course of sickle cell disease in patients treated with hydroxyurea

29. CD34+ selected stem cell boosts can improve poor graft function after paediatric allogeneic stem cell transplantation

31. Abstract 2008: The oncogenic fusion protein DNAJB1-PRKACA can be actively targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma

32. LGG-51. Resection extent and BRAF V600E mutation status determine postoperative growth velocity in pediatric Low-grade glioma: Results from a single-center cohort analysis

33. QOL-10. Treatment-induced leukoencephalopathy in pediatric medulloblastoma survivors and its impact on long-term neurocognitive functioning

35. Early Reconstitution of Antibody Secreting Cells after Allogeneic Stem Cell Transplantation

36. Evaluating the safety of perioperative dexamethasone treatment: A retrospective analysis of a single center pediatric low‐grade glioma cohort.

37. Cytogenetically cryptic TNIP1-PDGFRB and PCM1-FGFR1 fusion leading to myeloid/lymphoid neoplasms with eosinophilia (MLN-eo) in children

38. Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations

41. Blinatumomab in pediatric patients with relapsed/refractory B‐cell precursor acute lymphoblastic leukemia

Catalog

Books, media, physical & digital resources